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Abstract From March 1963 through June 1976, 111 patients received orthotopic 
liver homografts. Forty-two of the recipients had congenital biliary atresia. Other 
common diagnoses were chronic aggressive hepatitis, Laennec's cirrhosis. and pri-
mary hepatic malignancy. There were also other assorted, less common diagnoses. 
Thirty-one of the 111 patients (28%) lived at least one year and 15 are still alive with 
follow-ups of O~ to U~ years. Seven of the patients lived for more than five years. and 
6 of these 7 are still alive. In 1975 and 1976, clinical-pathologic correlations on all 
these patients were carried out with Professor K. A. Porter of London. The most 
common causes for failure were technical misadventures, including biliary tract 
problems, vascular thromboses, and the use of ischemically damaged livers. Rejec-
tion was less of a problem than had been realized. In view of these findings. improve-
ments in intraoperative and postoperative management were made with particular 
reference to biliaI)' tract drainage and to the use of microvascular techniques. Treat-
ment of a new series of 30 patients was begun in July 1976. and completed in De-
cember 1977. After 6 to 22 months. 15 of the 30 most recently treated patients are 
alive, all li\'ing outside the hospital. Thus, the outlook after transplantation appears 
to have greatly improved, and a one-year survival rate of 50% is projected. 
In this paper. I would like to discuss what is still 
classified as an experimental operation. namely total 
removal of the Ih'er and its replacement with a cada\'eric 
hepatic homograft. 
EXPERIMENTAL BACKGROUND 
Before discussing transplantation in humans. I 
would like to sketch in some of the background work 
which preceded our clinical efforts by a number of years. 
Following liver replacement in dogs. the new lh'er func-
tions for the few first postoperative days (1-3). but after 
four or five days (as also with renal and cardiac grafts) 
rejection supervenes. The animals become progressively 
jaundiced, and serum transaminase levels become ele-
vated. denoting necrosis of the graft. Almost all animals 
die within 10 days. Survival of an outbred dog for more 
than a month without immunosuppressive treatment has 
never been recorded. 
Histopathologically, the rejected canine grafts are 
overrun with mononuclear cells. mostly lymphocytes, 
which are the hallmarks of cell-mediated graft rejection. 
There is evidence as well of massive tissue necrosis 
caused by the rejection process. 
About 14 years ago, we showed that it was possible 
in some dogs to prevent rejection by the administration 
of azathioprine Efmuran~I Burroughs Wellcome) as the 
sole jmmunosuppressive treatment (4). The dog whose 
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course is shown in Fig I received a liver graft in March 
1964. This animal never became jaundiced. Furthermore. 
we realized from the early experiments that many such 
animals could have immunosuppression discontinued, 
sometimes at surprisingly early times (in the case shown 
in Fig 1 after only 4 months), and with subsequent long 
survival. This dog lived for 12 years postoperatively, fi-
nally dying of a combination of old age and partial 
biliary tract obstruction. 
The only other agent in the experimental labora-
tory that has substantially prolonged liver graft survival 
has been antilymphocyte serum (ALS) or antilymphocyte 
globulin (ALG) (5, 6). In some experiments. big doses of 
ALS or ALG were given before the arrival of the graft but 
no treatment at all was provided postoperatively. One 
such canine recipient of a nonrelated mongrel liver graft 
lived for several years after the transplantation. 
My personal background for liver transplantation 
thus was acquired in laboratories, first in Chicago and 
later at the University of Colorado. I would be remiss not 
to specifically note the great pioneering work in experi-
mental liver transplantation performed by Dr. Francis D. 
Moore of the Peter Bent Brigham Hospital (t, 7). 
Moore's contributions and publications have been com-
pletely annotated elsewhere (6). 
INDICATIONS FOR CLINICAL 
TRANSPLANTATION 
Leaving the laboratory behind. I tum now to clini-
cal liver transplantation. starting with possible indica-
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Fig I. Serum biochemistries during the II years and 8'n months of survival following canine orthotopic liver transplantation 
on March 23. 1964. The values recorded during the last eight months of life represent individual determinations. All other points 
on the graph are mean values for each time period; the brackets indicate I SD above and below the mean. Beginning with the 7th 
year of follow-up. bilirubin concentrations. if normal. were reported as < 1.2 mg.llOO ml. The upper limit of normal in our 
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tions for this procedure as we perceive them to be at the 
present time. Of all the indications for this operation it 
seems to me that biliary atresia is the most unequivocal. 
These children are crippled from birth. Society makes a 
great investment into their lives. from which no con-
ceivable longterm benefit can be expected. With deadly 
regularity they die and at a fairly predictable time. 
Under such circumstances, it has been reasonable to in-
tervene with a clear conscience before the patients reach 
a moribund state. In our series. biliary atresia h~ been 
the single most common reason for liver transplantation. 
Alcoholic cirrhosis is one of the most important 
potential indications for liver transplantation. but the 
timing of operation may be difficult to decide. particu-
larly if abstinence from alcohol is not achieved in ad-
vance. Furthermore. the damage done to the central 
nervous system by hepatic failure. and the consequential 
damage to other organ systems inflicted by self abuse or 
metabolically constitute a severe handicap. One of our 
most noted patients with Laennec's cirrhosis was the 
fermer King Peter of Yugoslavia. who was deposed dur-
ing the second World War. He was unconscious when he 
was taken to the operating room. His new liver 
functioned perfectly. but he died without regaining con-
sciousness. Only recently have our results with Laennec's 
cirrhosis provided any encouragement. 
Chronic aggressive hepatitis has been another 
common indication for Ih'er transplantation. The ideal 
patient would be virus free, but some transplant recip-
ients have had preexisting Australia antigenemia. The 
first long term survivor who had the HBsAg marker be-
came Australia antigen-negative as judged by agarose gel 
and complement fixation methods and remained that way 
for about two months (Fig 2). Her course indicated that 
the major focus of the virus had been in her native liver 
but later testing with the more sensitive radioimmunoas-
say showed that trace quantities of HB.Ag were always 
present. About two months postoperatively. at about the 
time when she would have expected to develop serum 
hepatitis had she been infected de novo at the time of 
transplantation. she had increases in bilirubin. rises in 
transaminases. joint pains. and a return positive HB,Ag 
as determined by aU the screening tests. Immunosuppres-
sion was not increased. She recovered spontaneously. but 
remained HB,Ag-positive and slowly recapitulated a vat-
iation of her original disease. She died after almost two 
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Fig 2. Course of the patient before and after liver replacement. AG: agarose gel immunodiffusion test for HB.Ag. 
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years. In spite of this experience, we doubt if the presence 
of a virus in these patients contraindicates liver trans-
plantation. It has become possible to treat such patients 
with specific hyperimmune globulin starting on the day of 
operation when the titer of the virus is made low by re-
moval oft he native liver. We have obtained clearing ofthe 
virus for many postoperative months, as have CaIne et a!. 
(8). 
Another indication which is especially interesting 
to pediatricians is a group of inborn errors of metabolism 
which are liver-based. It seems clear that all hepatic 
based inborn errors of metabolism are curable by suc-
cessful hepatic transplantation, even some disorders in 
which the exact enzyme defect is not known. As example 
of the latter is Wilson's disease, victims of which ac-
cumulate copper in the liver, brain and elsewhere. This 
accumulation of copper causes the lesions of Wilson's 
disease, which include the typical Kayser-Fleischer 
rings in the eyes. Wilson's disease is an inherited disor-
der in which most patients have reduced or absent serum 
ceruloplasm. After hepatic transplantation for Wilson's 
disease. the ceruloplasm increased in one of our patients 
from essentially zero to normal levels. and it remained 
normal for more than seven years post-transplantation 
(Fig 3). After operation. decoppering was evident in a 
cupruresis of many months' duration (Fig 3). In this pa-
tient, whose most important indication for operation was 
progressive neurologic disability, the nervous sytem 
changes reversed over several years and between two and 
three years postoperatively the Kayser- Fleischer rings 
disappeared. 
Other examples of inborn errors that we have 
treated include alpha-I-antitrypsin deficiency, congeni-
tal tyrosinemia. and Type IV glycogen storage disease. 
The possibilities for further research with other inborn 
errors are obvious. 
Finally, I would like to say something about he-
patic transplantation for the treatment of hepatic malig-
nancy. When we initially carried out liver replacement, 
we thought that primary liver tumors would be an ideal 
reason for proceeding. The idea was that otherwise non-
resectable hepatomas which were still localized to the 
liver could be treated by removal of the entire liver. This 
proved to be a vain hope for the most part, since recur-
rence of tumor has been seen in more than 90% of such 
trials with hepatomas, small duct cell carcinomas 
(Klatskin tumors), and other less common malignancies 
including hemangio-endothelial sarcoma (6, 9). With 
hepatomas. serial alphafetoprotein determinations have 
helped follow the evolution of metastases. With all kinds 
of tumors, a striking tendency has been seen for the re-
currences to "home" back to the graft itself. 
As with every rule, there is an exception to the 
tumor recurrence story. The exception in our series is a 
little girl who had a hepatoma as an incidental finding in 
a liver that was amicted with biliary atresia. Preopera-
tively, she had a positive alphafetoprotein examination. 
The abnormal protein disappeared after the surprisingly 
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Fig 3. The course of a patient with Wilson's disease who received an orthotopic liver homograft more than seven years ago. 
Note that the ceruloplasmin rose from undetectable to normal levels and that there was.a heightened urinary copper excretion 
for almost a year. In this patient cyclophosphamide and azathioprine were used interchangeably. The deterioration in liver 
function starting just after a month was caused by serum hepatitis (HBIAg). 
Reprinted. with permission. from Croth CC ct a/~ llctabolic dlocts of hepatic replac:ement in Wil5Oll's diJcasc. Transplantation Proc 5(1): 829-813.1973 
long interval of four months. She has remained al-
phafetoprotein negative and tumor-free since that time. 
She is now 81/, years post-transplantation and the 
longest surviving liver recipient in the world. 
In addition. significant palliation has been possi-
ble in some other cases in spite of tumor recurrence. We 
have treated two men with small duct cell carcinomas 
(Klatskin tumors) at the confluence of the right and left 
hepatic ducts. One Ih'ed for two years before dying of 
metastases. The other is surviving but with recurrent 
tumor; it has been four years since his operation. We 
have a female patient for whom we performed liver re-
placement almost two years ago for a sclerosing cholan-
giocarcinoma. She has small quiescent pulmonary 
metastases which have been present since the time of 
transplantation. Perhaps the door is not entirely closed 
on hepatic malignancy as an indication for liver trans-
plantation, although for the reasons I have stated, the 
yield in terms of cure will be small. 
To summarize indications in more general terms. 
we think: 1) ideal recipients should be less than 40 years 
old. Those who are older cannot stand the rigorous im-
munosuppression which must be imposed. 2) The patient 
should have a hopeless prognosis. a point to which I will 
return in a moment. 3) The patient should not have 
cancer. 4) The patient should not have an infection. As I 
have already implied, we have violated each of these 
guidelines from time to time. If two adverse conditions 
are present, the outlook is virtually hopeless. 
I would like to focus momentarily on the question 
of what constitutes a hopeless prognosis. We have treated 
patients with acute liver disease caused by halothane. 
isoniazid. and viruses-patients who seemed to have no 
hope for survival. Yet they have recovered fully with 
supportive care including ventilation. exchange transfu-
sion and renal dialysis. Because of such admittedly un-
common experiences. we are reluctant to proceed with 
liver replacement for acute disease. Perhaps in such cases 
auxiliary transplantation could play a role, whereby a 
second ectopically placed liver could be used temporar-
ily to tide the patient over the crisis and to allow recov-
ery of the native liver. 
In patients with chronic liver disease. it is impor-
tant to have a longitudinal view of their course of illness 
before accepting them for transplantation. Such a view 
has been made possible by collaboration with a number 
ofstudents ofliver disease. We have developed a network 
of communication with many prominent hepatology cen-
ters in the United States. When referrals come from such 
sources, we have confidence that the time Is ripe for 
treatment, even if our own opportunity for observation is 
limited. When a patient becomes Invalided so he or she 
cannot function in society and cannot work. we believe 
further delay is inadvisable. The past practice of taking 
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Fig 4. Technique of retrograde removal of liver. A. Incisions. AA indicates subcostal incision 
used for all orthotopic liver transplantations. BB. CC and DD indicate frequently used extension 
from the AA incision. B. Beginning retrograde removal after transection of inferior vena cava 
and hilar structures. All posterior tissue that is cut should be ligated. although the named vessels 
encountered. such as the right adrenal vein. are few in number. 
Reprinted. ""ith p<'rmission. from Starzl TE .. aI.: Orthotopic fiyD~r transplanlation in nin~ty·thtft patients. Surg G}'necol Obotet 
142: 487-505,1970. 
moribund patients to the operating room for such an ex-
tensive procedure will not permit an improvement 
in results. 
TECHNIQUE OF LIVER REPLACEMENT 
The essential first step in liver transplantation is 
to obtain a good cadaveric organ from a brain dead 
donor in whom circulation is still effective. The organ 
can be excised in an orderly way and chilled by infusing 
cold fluid such as lactated Ringer's solution (with or 
without low molecular weight dextran) through the por-
tal vein. The cooled liver will tolerate several hours of 
ischemia. 
_ An important practical breakthrough in the last 
two or three years has been the infusion of cadaveric 
livers with special solutions which mimic plasma (10) or 
alternatively which have an electrolyte composition 
similar to that in cells (ll). The latter fluid, which is 
known as Collins' solution. has permitted the cold pres-
ervation of canine livers safely in our laboratories for 12 
to 18 hours. As a clinical extension. it has been possible 
for us to harvest human livers in California. Minnesota 
and other distant places. carry the livers to Denver on 
commercial airplanes. and successfully transplant the 
organs in Colorado. Thus. the possibility ot a national 
liver procurement network has emerged. ',;;.. _ . . 
In the meanwhile. the recipient opef8tion IsUsu-
ally done thrpugh a basic subcostal incision, very often 
with an extension into the right chest through the 
seventh intercostal space or with a superior midline ex-
tension including excision of the xiphoid process (Fig 4). 
There usually are formidable technical problems because 
:-
. I 
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Fig 5. C. Operative field after retrograde liver mobilization. The last remaining stnx:ture, the 
suprahepatic inferior vena cava. has been clamped above the liver. D. Technique for mobilizing 
a suitable length of suprahepatic vena cava after placement of clamp. In adults. this usually 
involves cutting away cirrhotic liver tissue over the frequently distorted and foreshortened right 
and left hepatic veins. . 
Reprinted. with permission. from Starzl TE ctal.: Onhotopic linr transplantation In ni ..... ty·three patients. Su'l Gynccol ObslCt 
142: 487-505. 1976. 
of the extensive venous collaterals which can render 
hemostasis almost impossible. The problem is com-
pounded by the fact that dotting factors are never nor-
mal. In our early experience, most adult patients with 
cirrhosis lost 30 to 50 units of blood. Some technical 
modifications have improved the situation. Of these. the 
most important is removal of the liver by transecting aU 
of the structures entering it. removing it from below 
while pulling on the hilar structures. and ligating ail of 
the tissues that are cut behind. When the upper end of the 
liver is reached. a clamp can be placed across the su-
prahepatic vena cava, and a cuff of the vena cava can be 
d'eveloped for suture by dissecting off the cirrhotic liver 
(fig 5). 
In concept. liver transplantation is a simple opera-
lion which consists of connecting the blood vessels com-
ing into and going out of the liver in as normal a way as 
possible and then reconstituting biliary drainage (Fig 6). 
There are two vena caval anastomoseS, one below and 
one above the liver. for the last two years, we have con-
tinuously infused the homografts through the portal vein . 
during the time of the vena caval anastomoses, allowing . 
air bubbles trapped in the homograft to come out as the . 
suture lines were completed (Fig 7). Omission of this pre-
caution in early cases resulted in air embolus, particu-
larly in adult recipients (12). The air floated to the right . 
heart and because of the extensive venous anastomoses 
from right to left in patients with liver disease, these 
emboli passed straight to the left beart and up to the 
brain, causing grave neurologic dam._ ~K . _., 
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Fig 6. Techniques of biliary duct reconstruction used for most of the transplantation recipients. 
A. Cholecystoduodenostomy. B. Cholecystojejunostomy. C. Choledochojejunostomy after re-
moval of gallbladder. D. Choledochocholedochostomy. Note that the T-tube is placed. if possible, 
in recipient common duct. 
~prinlodI ,.·ith permission, from SIan! TE 01 al.: Onhotopic Ihor transplantalion in nirK"ly.thrtt pal~ntKI Sure G\'nC'COI Obit .. 
142: 4S7 - 505. 1976. 
For biliary reconstruction in most of our early 
cases, cholecystoduodenostomy (Fig 6A) was used be-
cause it was the simplest and fastest way to complete a 
long and tiring operation. The patients had an extraordi-
nary incidence of symptomatic or asymptomatic bac-
teremia (6). It seemed as if the liver itself was the focus of 
and the entry for bacteria that passed into the general 
circulation and then caused infections elsewhere. Ulti-
mately, it became obvious that contamination with gas-
trointestinal contents was causing cholangitis. 
Consequently, we now believe that the ideal way of 
reconstructing the biliary tract is simple end-to-end 
common duct anastomosis (Fig 60). Of course in many 
patients (children with biliary atresia, for example) this 
option is not available. Then, we perform cholecys-
tojejunostomy (Fig 6B) or choledochojejunostomy (Fig 
6C), anastomosing gall bladder or the common duct to a 
Roux limb of jejunum. The Roux principle de-
functionalizes a loop of the intestine, theoretically allow-
ing the gastrointestinal stream to pass distally to the 
liver without seriously contaminating it. 
IMMUNOSUPPRESSION 
Immunosuppressive therapy in liver recipients (6, 
9) is much the same as was developed at our center for 
kidney transplantation. It consists of triple drug therapy 
(Figs 2 and 3) with azathioprine (which may be replaced 
with cyclophosphamide), with prednisone and with 
heterologous antilymphocyte globulin (ALG). ALG is 
purified immunoglobulin obtained from the serum of 
horses or rabbits immunized against human lympho-
cytes. Thus ALG administration is an attempt at lym-
phoid depletion. The only reatly dose-maneuverable 
component of the triple drug regimen Is prednisone, 
. which is raised or lowered according to the presence or 
absence of rejection: 
.. 
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Fig 7. Technique to prevent air embolism from orthotopic liver homografts. A. Continuous perfusion of solution through portal 
vein as vena caval anastomoses are constructed. B. C. Escape of air bubbles as the anastomoses are completed. 
J«prinlcd. wilh ~rmi .. ion. from stan! YE et aI.: Acute nnuolopcal Qlmplications after liver transplantation with panicular reference 10 intraopentlft cerebral air 
embolus. Ann Suzy 187: 236-2010. 1971. ' 
POSTOPERATIVE COMPLICATIONS AND 
CAUSES OF FAILURE 
The high mortality after liver transplantation has 
prevented wide application of this procedure. In the 
summer of 1975. I had the opportunity during a sabbati-
cal leave in London to review the first 93 consecutive 
Colorado cases with Professor K. A. Porter. who is a 
world authority on transplantation pathology. We tried 
in each case to determine the reasons for success or fail-
ure. The details of this work have been published (9). I 
would like to briefly recount the central findings, be-
cause they changed our attitudes about management for 
all subsequent cases. .. 
One expected cause of failure was uncontrolled 
acute rejection. However. it was surprising how rel.- . 
lively infrequently (about 20% of the patients) this was the " 
primary reason for death. Similarly, chronic rejection.k 
with its typical occlusive vascular lesions and paren- .... 
chymal fibrosis. accounted for only a few failures. 
What then were the main reasons for the exorbi-
tant mortality up to that time? The majority of deaths K~ 
were found to result from technical or mechanical probe,; 
lems. These included DhroD:DMI;~:the hepatic arte<y:l ~ 
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fig 8. Transhepatic choJangiograms in four patients whose original biliary reconstructions were 
with Roux-en·Y cholecystojejunostomy. as depicted in Figure 6B. A. Minimal obstruction. B. 
Moderate obstruction. C. Severe obstruction with leak and abscess formation (A) near site of 
common duct ligation. D. Very severe obstruction. At rC9pera tion the com mon duct was necrotic:. 
C = common duct; CD = cystic duct; GB = gallbladder; J = jejunum; large arrows" sites of 
common duct ligation. 
Reprinted. with permission. from Starzl TE et .1.: Biliary complications .rlotr Ii,'er transplantation: With s"""ial ~Krence to the 
biliar:' cast syndrome and techoiq,,",' or secondary duct repair. Sursery 81: 212-221. 1977. 
portal vein. the use of grafts damaged by ischemia. the 
development of cerebral air embolus as discussed earlier. 
and hemorrhage. to mention just four examples. 
However. by far the greatest single technical cause 
of mortality was failure of the biliary tract reconstruc· 
tion. In the 93 consecutive cases analyzed in London. 
almost 35% of the patients had either obstruction of or 
fistula formation from their biliary tracts (13). Half of 
these patients were not treated with reoperation. One 
excuse was that the reconstructions usually had been 
with cholecysto- or choledochoenterostomy. It was nol 
possible to make the diagnosis by means which are now 
standard. such as percutaneous transhepatic choJangiog. 
. raphy using the so·called skinny (Chiba) needle. We 
awakened to the fact that patients who became jaun· 
diced in the postoperative period were not necessarily 
undergoing rejection. but that there was a good possibil· 
ity of obstruction. 
Using cholangiography frequently. the kinds of 
obstructive lesions seen in Fig 8 were discovered with 
increasing frequency and ducts were reconstructed sec· 
ondarily. oeope~ation and secondary repair of these di-
lated duct systems was shown to be safe (13). 
CLINICAL RESULTS 
I have presented an overview of some general 
principles in liver traneplantation. and will conclude 
with some statistics and follow-ups which were recently 
brought up to date. The material can be spUt Into two 
phases. 
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Total 
Lived > 1 year 
Alive now 
TABLE 1 
Total Number of Patients· 
111 
31 (28%) 
15 (After 2Y.J-8Y.J years) 
• March 1963 through July 1976. Follow-up to April 13. 1978. 
To June 1976 
The first phase was prior to the clinical-pathologic 
correlations which began in the summer of 1975 and 
were completed in early 1976. There were III consecu-
tive patients who were treated between 1963 and June 
1976. Only 31 (28%) lived for as long as 1 year (Table I). 
Of the 31 patients that lived for a year, 15 are still surviv-
ing after 2'1l to 8'1l years. 
Amongst the 111 original patients, there were 50 
adults (Table 11), including 13 with malignancies. Sev-
eral of these 13 died of recurrent malignancy as stated 
earlier, before or after 1 year. Chronic aggressive hepati-
tic and alcoholic cirrhosis were the other common dis-
eases treated. In all of the major diagnostic categories, 
extended survival was uncommon. Only 10 (20%) of the 
50 patients lived for as long as a year, and 5 are stiJl 
surviving with follow-ups as short as 28 months and as 
long as about 4 years. The woman with the Budd-Chiari 
syndrome has had a baby. The patients who died late had 
survivals of 13'h to 25 months (Table IU. 
In the first III patients there were 61 who were 18 
years or younger. In this pediatric subdivision there were 
42 examples of biliary atresia with a one-year survival of 
only 12 (29%). In the assortment of other diagnoses were 
included the inborn errors of metabolism, hepatomas, 
and chronic aggressive hepatitis (Table III). Twenty-one 
(34%) of the total pediatric series of 61 Ii\'ed for a year. 
Ten are still alive with follow-ups of 3'h to 8'/l years 
(Table IV). The 12 late deaths were after one to six years. 
The most remote death was a particularly tragi'c one 
caused by a biliary duct complication six years following 
liver replacement for Wilson's disease. Thus. the overall 
survival in the pediatric series was better than among 
adults but still poor. 
After June 1976 
Improvements in technical and diagnostic care 
were instituted after the case reviews which took place in 
1975 and early 1976. These included the use of microvas-
cular techniq~es for vascular anastomoses and the more 
liberal use of postoperative cholangiography and needle 
biopsy. Since then and with a cut-off of December 1977, 
we accumulated 30 more cases (Table V). The sUrvival in 
the latest group is now 50%. Fourteen of the 15 survivol'l' 
are more than 6 months postoperative and 9 are more 
than a year postoperative. All of these patients are out of 
the hospital, and from past experience it seems clear to 
us that the one-year overall mortality of liver transplan-
tation is now approximately 50%.' 
A breakdown of the recipients in the adult and 
pediatric subgroups is given in Table VI. The survival in 
both categories is about double that of the original series. 
Perhaps a new era in liver transplantation is at hand. 
SUMMARY 
The development of liver transplantation has been 
a tortured and often sad story. just as was the story of 
renal transplantation. It appears that substantial ad-
vances have been made mostly because of better surgical 
techniques and because of better management. It has 
been necessary for surgeons to act more like internists. 
, As of July 17. 1978, no further deaths had occurred. 
TABLE II 
Fate of First 50 Adult Patients· 
Number of Survival 
Diagnosis Examples 1 Year Alive Nowt ' 
Malignant tumort 13 2 (159&) 1 (44 months) 
Chronic aggressive hepatitis 17 5 (309&) 1 (32 months) 
Alcoholic cirrhosis 11 1 (99&) I (49 months) 
Primary biliary cirrhosis 4 0 (09&) 0 
Secondary biliary cirrhosis 1 0 (09&) 0 
Sclerosing cholangitis 
with ulcerative colitis 0 (09&) 0 
Massive hepatic necrosis 
due to hepatitis B virus 0 (09&) 0 
Budd-Chiari syndrome ,1 (1009f,) I (43 months) 
Congenital biliary hypoplasia 1 (1009&) I (28 months) 
·March 1963 through July 1976. Follow-up to April 13. 1978. . 
t 7 hepatomas, 4 duct cell carcinomas, 1 cholangiocarcinoma. and 1 hemangioendothelial sarComa. T1te patient who is still alive 
had a small obstructing duct cell carcinoma. . 
* The 5 deaths after 1 year occurred after 1P~K 1R~K 19, OM~I and 25 months. 
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TABLE III 
Fate of First 61 Pediatric Patients· 
Diagnosis 
Congenital biliary atresia 
Chronic aggressive hepatitis 
Hepatoma 
Wilson's Disease 
Congenital biliary cirrhosis 
Alpha-J -antitrypsin deficiency 
Tyrosinemia 
Giant cell hepatitis 
TOTAL 
Number of 
Examples 
42 
10 
3 
2 
I 
1 
I 
J 
6J 
Survival 
I Year 
J2 (29%) 
3 (30%) 
2 (67%) 
2 (100%) 
J (100%) 
1 (100%) 
o (0%) 
o (0%) 
21 (34%) 
• March 1963 through July 1976. Follow-up to April 13, 1978. 
TABLE V 
Last 30 Cases of Liver Transplantation· 
Total cases 
Alive 
Dead 
30 
1St 
15 
• August 1976 through December 1977. Follow-up to April 13. 
1978. 
t 0.6 months = 14. ;;.1 year" 9. 
and to be more SUSPIClOUS and inquisitive about the 
reasons for post-transplantation liver dysfunction rather 
than to ascribe hepatic perturbations to rejection_ With 
these nonspecific improvements. there has been move-
ment of liver transplantation into the area of actual 
service. 
Before the next great step will be made. it is my 
feeling that there must be an improvement in im-
munosuppression of the kind which will also permit a 
more satisfactory level of service to be achie\'ed in renal 
and other kinds of transplantation. Just exactly what the 
improvement will consist of I do not know. The state of 
the art of immunosuppression has been frozen in its pres-
ent form for almost ten years. Nothing in medicine is 
ever allowed to remain stationary for much longer than 
that. If improvements in immunosuppression can be 
made liver transplantation will be catapulted into a kind 
of definitive service which will be comparable in 
hepatology to the use of renal transplantation and 
dialysis in nephrology. 
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